Enhanced skin carcinogenesis in Cyclin D1-conditional transgenic mice: Cyclin D1 alters keratinocyte response to calcium-induced terminal differentiation

Cancer Research

Volumn 62, Issue 6, 2002, Pages 1641-1647

  Yamamoto, Hanako ^a   Ochiya, Takahiro ^a   Takeshita, Fumitaka ^d   Toriyama Baba, Hiroyasu ^b   Hirai, Kotaro ^a   Sasaki, Hideo ^a   Sasaki, Hiroki ^c   Sakamoto, Hiromi ^c   Yoshida, Teruhiko ^c   Saito, Izumu ^e   Terada, Masaaki ^a,c  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b Chemotherapy Division   (Japan)

^c StaGen   (Japan)

^d NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CYCLIN D1; DIMETHYLBENZ[A]ANTHRACENE; MESSENGER RNA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE MUTATION; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN CANCER; SKIN CARCINOGENESIS; TRANSGENE; TRANSGENIC MOUSE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CALCIUM; CARCINOGENS; CELL DIFFERENTIATION; CELL DIVISION; CYCLIN D1; GENE EXPRESSION REGULATION; GENES, RAS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KERATINOCYTES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; SKIN NEOPLASMS;

EID: 0037086276     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Deregulation of the cell cycle in cancer
2. Cell division cycle alterations and human tumors
3. Cancer cell cycles
4. Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein
5. Perturbation of cell cycle regulators in human cancer
6. Aberrant expression of cyclin D1 in pulmonary proliferative lesions induced by high doses of urethane in transgenic mice carrying the human prototype c-H-ras gene
7. Modulation of cyclin gene expression by adenovirus E1A in a cell line with E1A-dependent conditional proliferation
8. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
9. Transgenic mouse models of human breast cancer
10. Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information
11. Amplification and overexpression of EXP1 and EXP2/cyclin D1 genes in human esophageal carcinomas
12. Amplified genes in cancer in upper digestive tract
13. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining
14. Expression of molecular biomarkers in primary breast tumors implanted into a surrogate host: Increased levels of cyclins correlate with tumor progression
15. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions
16. D-type cyclins
17. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression
18. 1phase in rodent fibroblasts
19. Deregulated expression of cyclin D1 overrides antimitogenic signals
20. Cyclin D1 overexpression in mouse epidermis increases cyclin-dependent kinase activity and cell proliferation in vivo but does not affect skin tumor development
21. The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach
22. A transgenic mouse model with cyclin D1 overexpression results in cell cycle, epidermal growth factor receptor, and p53 abnormalities
23. Cyclin D1 overexpression combined with N-nitrosomethylbenzylamine increases dysplasia and cellular proliferation in murine esophageal squamous epithelium
24. Genetic factors controlling responsiveness to skin tumor promotion in mice
25. Murine susceptibility to two-stage skin carcinogenesis is influenced by the agent used for promotion
26. Keratinocyte cell-mediated mutagenesis assay: Correlation with in vivo tumor studies
27. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase
28. Tumorigenicity and gene amplification potentials of cyclin D1-overexpressing NIH3T3 cells
29. A simple and efficient method for purification of infectious recombinant adenovirus
30. Altered differentiation of mouse epidermal cells treated with retinyl acetate in vitro
31. Quantitative assay for carcinogen altered differentiation in mouse epidermal cells
32. Mouse skin cells resistant to terminal differentiation associated with initiation of carcinogenesis
33. Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia
34. Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo
35. Molecular analysis of chemical carcinogenesis in the skin
36. Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression
37. The pathogenesis of squamous cell cancer: Lessons learned from studies of skin carcinogenesis - Thirty-third G. H. A. Clowes Memorial Award Lecture
38. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis
39. Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas
40. Ras activity and cyclin D1 expression: An essential mechanism of mouse skin tumor development
41. Early overexpression of cyclin D1 protein in mouse skin carcinogenesis
42. Positive immunohistochemical staining of p53 and cyclin D in advanced mouse skin tumors, but not in precancerous lesions produced by benzo[a]pyrene
43. Overexpression of cyclin D1 in mouse skin carcinogenesis